BeiGene Regains Full Global Rights to Its Investigational Anti-PD-1 Antibody Tislelizumab

NEXT STORY
Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.
PREV STORY
Laboratory Reagents – World Market to 2022: Molecular Biology, Biochemistry, Cytokine & Chemokine Testing, Cell/Tissue Culture, Carbohydrate Analysis, Immunohistochemistry, and Environmental Testing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AVEO Oncology Announces Participation at the H.C. Wainwright Virtual BioConnect 2022 Conference

author_avatar
NASDAQ Market News

Sanofi’s investigational enzyme replacement therapy shows clinically meaningful improvement in critical manifestations of late-onset Pompe disease

author_avatar
NASDAQ Market News

Ultimovacs Announces Further Positive Topline Results from Phase I UV1 Cancer Vaccine Combination Study in Metastatic Melanoma

author_avatar
NASDAQ Market News